Skip to main content
CI
NYSE Finance

Cigna Group Reports Strong Q1 Results, Raises Full-Year 2026 Outlook

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Positive
Importance info
8
Price
$293.01
Mkt Cap
$77.073B
52W Low
$239.51
52W High
$350
52W Position info
22% above low
Off High info
16% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

CI sits 22% above its 52-week low of $239.51.

Summary

Cigna Group announced strong first-quarter 2026 earnings, with revenues and adjusted income from operations significantly increasing year-over-year, leading to an upward revision of its full-year 2026 earnings outlook.


Key Events · Earnings and Guidance · CI

  • Strong Q1 2026 Financial Performance

    Total revenues increased 5% to $68.5 billion, and adjusted income from operations per share rose 15.6% to $7.79 compared to the first quarter of 2025.

  • Raised Full-Year 2026 Outlook

    The company increased its adjusted income from operations outlook to at least $30.35 per share, an increase of $0.10 from the prior projection.

  • Improved Operational Efficiency

    The SG&A expense ratio decreased to 5.4% (adjusted 4.8%), and the Cigna Healthcare medical care ratio improved to 79.8% from 82.2% in Q1 2025.

  • Debt-to-Capitalization Ratio Improvement

    The debt-to-capitalization ratio improved to 42.3% at March 31, 2026, down from 43.0% at December 31, 2025.


Analysis · CI · Finance

The Cigna Group delivered robust first-quarter 2026 financial results, exceeding prior year performance with a 5% increase in total revenues and a 15.6% rise in adjusted income from operations per share. The company also raised its full-year 2026 adjusted income from operations outlook, signaling continued confidence in its operational execution and strategic initiatives. Key operational improvements include a lower SG&A expense ratio and an improved Cigna Healthcare medical care ratio, contributing to a positive financial trajectory.

How filings like this one have moved

In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CI was trading at $293.01 on NYSE in the Finance sector, with a market capitalization of approximately $77.1B. The 52-week trading range was $239.51 to $350.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CI - Latest Insights

CI
Oct 01, 2026, 3:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $271.83
Real-time Price: $272.00 info
Change: +$0.170 (+0.06%) info
Market Cap: $71.828B info
CI
Sep 30, 2026, 7:53 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $274.00
Real-time Price: $272.00 info
Change: -$2.00 (-0.73%) info
Market Cap: $71.828B info
CI
Sep 30, 2026, 7:12 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $274.00
Real-time Price: $272.00 info
Change: -$2.00 (-0.73%) info
Market Cap: $71.828B info
CI
Sep 29, 2026, 12:24 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $273.21
Real-time Price: $272.00 info
Change: -$1.21 (-0.44%) info
Market Cap: $71.828B info
CI
Jul 30, 2026, 2:15 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $288.42
Real-time Price: $272.00 info
Change: -$16.42 (-6%) info
Market Cap: $71.828B info